$PFX
PhenixFIN Corp Stock $pfx

$pfx Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000121390023009500 Filed on February 09, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022 Q3
Revenue	$4.912M	$1.649M	$5.095M
YoY Change	34.32%	-47.38%	16.66%
Cost Of Revenue	$1.382M	$1.233M	$1.203M
YoY Change	13.15%	-17.11%	-4.66%
Gross Profit	$3.531M	$3.470M	$3.892M
YoY Change	44.94%	110.87%	25.32%
Gross Profit Margin	71.88%	210.48%	76.39%
Selling, General & Admin	$1.756M	$1.821M	$2.019M
YoY Change	36.58%	26.01%	-0.53%
% of Gross Profit	49.74%	52.49%	51.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.756M	$1.821M	$2.019M
YoY Change	36.58%	26.01%	-0.53%
Operating Profit	$1.775M	$1.649M	$1.873M
YoY Change	54.27%	723.88%	74.1%
Interest Expense	$4.934M	$1.203M	-$6.527M
YoY Change	170.72%	-75.44%	-19.59%
% of Operating Profit	278.03%	72.97%	-348.42%
Other Income/Expense, Net	$200.0K	$200.0K
YoY Change
Pretax Income	$6.708M	$3.952M	-$4.653M
YoY Change	125.66%	-17.72%	-33.9%
Income Tax
% Of Pretax Income
Net Earnings	$6.708M	$3.952M	-$4.653M
YoY Change	125.66%	-17.72%	-33.9%
Net Earnings / Revenue	136.56%	239.7%	-91.33%
Basic Earnings Per Share	$3.20	$1.88
Diluted Earnings Per Share	$3.20	$1.88	-$2.139M
COMMON SHARES
Basic Shares Outstanding	2.097M shares	2.101M shares
Diluted Shares Outstanding	2.095M shares	2.101M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.76M	$17.65M	$22.77M
YoY Change	-71.43%	-70.27%	-67.21%
Cash & Equivalents	$10.76M	$17.70M	$22.77M
Short-Term Investments
Other Short-Term Assets	$124.3K	$384.6K	$489.2K
YoY Change
Inventory
Prepaid Expenses
Receivables	$725.7K	$1.713M	$727.6K
Other Receivables	$662.9K		$690.8K
Total Short-Term Assets	$12.28M	$20.72M	$24.68M
YoY Change	-68.35%	-67.63%	-65.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$444.5K	$478.6K	$513.1K
YoY Change	-25.91%	-20.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$200.1M	$183.3M	$193.0M
YoY Change	5.71%	4.49%	27.25%
Other Assets	$848.3K	$1.054M	$1.193M
YoY Change
Total Long-Term Assets	$201.7M	$184.7M	$194.2M
YoY Change	5.97%	4.54%	26.89%
TOTAL ASSETS
Total Short-Term Assets	$12.28M	$20.72M	$24.68M
Total Long-Term Assets	$201.7M	$184.7M	$194.2M
Total Assets	$213.9M	$205.4M	$218.9M
YoY Change	-6.62%	-14.66%	-2.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.366M	$1.042M	$16.55M
YoY Change	-86.83%	-91.38%	786.77%
Accrued Expenses	$1.172M	$1.038M	$1.074M
YoY Change	6.27%	5.29%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.567M	$2.148M	$3.189M
YoY Change	-69.12%	-83.73%	114.83%
LONG-TERM LIABILITIES
Long-Term Debt	$78.88M	$78.07M	$77.96M
YoY Change	1.44%	0.55%	0.68%
Other Long-Term Liabilities	$337.3K	$473.0K	$327.9K
YoY Change	-9.5%	18.35%	-46.56%
Total Long-Term Liabilities	$79.21M	$78.54M	$78.29M
YoY Change	1.39%	0.64%	0.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.567M	$2.148M	$3.189M
Total Long-Term Liabilities	$79.21M	$78.54M	$78.29M
Total Liabilities	$82.78M	$80.69M	$98.03M
YoY Change	-8.15%	-12.45%	20.43%
SHAREHOLDERS EQUITY
Retained Earnings		-$550.6M	-$554.6M
YoY Change
Common Stock		$675.3M	$675.4M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares		2.305K shares
Shareholders Equity	$131.2M	$124.7M	$120.8M
YoY Change
Total Liabilities & Shareholders Equity	$213.9M	$205.4M	$218.9M
YoY Change	-6.62%	-14.66%	-2.76%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022 Q3
OPERATING ACTIVITIES
Net Income	$6.708M	$3.952M	-$4.653M
YoY Change	125.66%	-17.72%	-33.9%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$6.646M	-$4.801M	$2.626M
YoY Change	-23.69%	-51.61%	-88.33%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$104.5K	-$3.975M
YoY Change			-33.12%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-244.0K	-$312.5K	-4.241M
YoY Change	-98.12%	138.68%	-28.65%
NET CHANGE
Cash From Operating Activities	-6.646M	-$4.801M	2.626M
Cash From Investing Activities
Cash From Financing Activities	-244.0K	-$312.5K	-4.241M
Net Change In Cash	-6.890M	-$5.114M	-1.615M
YoY Change	-68.25%	-49.13%	-109.75%
FREE CASH FLOW
Cash From Operating Activities	-$6.646M	-$4.801M	$2.626M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	dei	Document Type DocumentType	10-Q
CY2022Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q4	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q4	dei	Entity File Number EntityFileNumber	1-35040
CY2022Q4	dei	Entity Registrant Name EntityRegistrantName	PHENIXFIN CORPORATION
CY2022Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-4576073
CY2022Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	445 Park Avenue
CY2022Q4	dei	Entity Address Address Line2 EntityAddressAddressLine2	10th Floor
CY2022Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2022Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10022
CY2022Q4	dei	City Area Code CityAreaCode	(212)
CY2022Q4	dei	Local Phone Number LocalPhoneNumber	859-0390
CY2022Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q4	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q4	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2096772	shares
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	183271179	usd
CY2022Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	192956649	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17654080	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22768066	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	1712890	usd
CY2022Q3	us-gaap	Interest Receivable InterestReceivable	727576	usd
CY2022Q4	pfx	Paydown Receivable PaydownReceivable	400308	usd
CY2022Q3	pfx	Paydown Receivable PaydownReceivable	112500	usd
CY2022Q4	us-gaap	Dividends Receivable DividendsReceivable	269330	usd
CY2022Q3	us-gaap	Dividends Receivable DividendsReceivable	269330	usd
CY2022Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	36992	usd
CY2022Q4	pfx	Prepaid Share Repurchases PrepaidShareRepurchases	384637	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	332092	usd
CY2022Q3	pfx	Prepaid Share Repurchases PrepaidShareRepurchases	489156	usd
CY2022Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	50000	usd
CY2022Q4	us-gaap	Due From Affiliates DueFromAffiliates	301020	usd
CY2022Q3	us-gaap	Due From Affiliates DueFromAffiliates	271962	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1054413	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1192677	usd
CY2022Q4	us-gaap	Assets Assets	205379949	usd
CY2022Q3	us-gaap	Assets Assets	218874908	usd
CY2022Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	1955972	usd
CY2022Q3	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	2059164	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	78065828	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	77962636	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1042136	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	2040277	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	535267	usd
CY2022Q3	us-gaap	Other Liabilities OtherLiabilities	572949	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	503125	usd
CY2022Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	503125	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	472521	usd
CY2022Q3	us-gaap	Deferred Revenue DeferredRevenue	325602	usd
CY2022Q4	pfx	Administrator Expenses Payable AdministratorExpensesPayable	68267	usd
CY2022Q3	pfx	Administrator Expenses Payable AdministratorExpensesPayable	74911	usd
CY2022Q3	srt	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	16550000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	80687144	usd
CY2022Q3	us-gaap	Liabilities Liabilities	98029500	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2723709	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2723709	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2099824	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2102129	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2100	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	2102	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	675297285	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	675401802	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-550606580	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-554558496	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	124692805	usd
CY2022Q3	us-gaap	Assets Net AssetsNet	120845408	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	205379949	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	218874908	usd
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	59.38
CY2022Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	57.49
CY2022Q4	pfx	Interest Income On Non Control And Non Affiliate Investments Cash InterestIncomeOnNonControlAndNonAffiliateInvestmentsCash	1916041	usd
CY2021Q4	pfx	Interest Income On Non Control And Non Affiliate Investments Cash InterestIncomeOnNonControlAndNonAffiliateInvestmentsCash	1015692	usd
CY2022Q4	pfx	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	106187	usd
CY2021Q4	pfx	Payment In Kind Interest Income On Non Control And Non Affiliate Investments PaymentInKindInterestIncomeOnNonControlAndNonAffiliateInvestments	138511	usd
CY2022Q4	pfx	Interest Income On Affiliate Investments Cash InterestIncomeOnAffiliateInvestmentsCash	198453	usd
CY2021Q4	pfx	Interest Income On Affiliate Investments Cash InterestIncomeOnAffiliateInvestmentsCash	122147	usd
CY2022Q4	pfx	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments	89743	usd
CY2021Q4	pfx	Payment In Kind Interest Income On Affiliate Investments PaymentInKindInterestIncomeOnAffiliateInvestments	97028	usd
CY2022Q4	pfx	Interest Income On Controlled Investments Cash InterestIncomeOnControlledInvestmentsCash	194627	usd
CY2021Q4	pfx	Interest Income On Controlled Investments Cash InterestIncomeOnControlledInvestmentsCash	553638	usd
CY2022Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	2505051	usd
CY2021Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	1927016	usd
CY2022Q4	us-gaap	Investment Income Dividend InvestmentIncomeDividend	2032358	usd
CY2021Q4	us-gaap	Investment Income Dividend InvestmentIncomeDividend	702930	usd
CY2022Q4	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	92226	usd
CY2021Q4	us-gaap	Interest Income Money Market Deposits InterestIncomeMoneyMarketDeposits	2739	usd
CY2022Q4	pfx	Fees Income FeesIncome	73599	usd
CY2021Q4	pfx	Fees Income FeesIncome	270122	usd
CY2021Q4	us-gaap	Other Income OtherIncome	230434	usd
CY2022Q4	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	4703234	usd
CY2021Q4	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	3133241	usd
CY2022Q4	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1233176	usd
CY2021Q4	us-gaap	Interest And Debt Expense InterestAndDebtExpense	1487675	usd
CY2022Q4	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	857533	usd
CY2021Q4	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	505875	usd
CY2022Q4	us-gaap	Professional Fees ProfessionalFees	347917	usd
CY2021Q4	us-gaap	Professional Fees ProfessionalFees	306751	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	219977	usd
CY2021Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	196559	usd
CY2022Q4	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	194000	usd
CY2021Q4	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	208500	usd
CY2022Q4	us-gaap	General Insurance Expense GeneralInsuranceExpense	124084	usd
CY2021Q4	us-gaap	General Insurance Expense GeneralInsuranceExpense	158904	usd
CY2022Q4	pfx	Administrative Services Expense AdministrativeServicesExpense	77884	usd
CY2021Q4	pfx	Administrative Services Expense AdministrativeServicesExpense	68866	usd
CY2022Q4	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	3054571	usd
CY2021Q4	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	2933130	usd
CY2022Q4	us-gaap	Net Investment Income NetInvestmentIncome	1648663	usd
CY2021Q4	us-gaap	Net Investment Income NetInvestmentIncome	200111	usd
CY2022Q4	pfx	Realized Gain Lossfor Non Controlled Non Affiliated Investments RealizedGainLossforNonControlledNonAffiliatedInvestments	13448	usd
CY2021Q4	pfx	Realized Gain Lossfor Non Controlled Non Affiliated Investments RealizedGainLossforNonControlledNonAffiliatedInvestments	484513	usd
CY2021Q4	pfx	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments	14737897	usd
CY2021Q4	pfx	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments	925	usd
CY2022Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	13448	usd
CY2021Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	15223335	usd
CY2022Q4	pfx	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	1523099	usd
CY2021Q4	pfx	Unrealized Appreciation Depreciation On Non Control And Non Affiliate Investments UnrealizedAppreciationDepreciationOnNonControlAndNonAffiliateInvestments	131963	usd
CY2022Q4	pfx	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	715537	usd
CY2021Q4	pfx	Unrealized Appreciation Depreciation On Affiliate Investments UnrealizedAppreciationDepreciationOnAffiliateInvestments	-10473843	usd
CY2022Q4	pfx	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	51169	usd
CY2021Q4	pfx	Unrealized Appreciation Depreciation On Control Investments UnrealizedAppreciationDepreciationOnControlInvestments	17641	usd
CY2022Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2289805	usd
CY2021Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-10324239	usd
CY2021Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-296197	usd
CY2022Q4	pfx	Total Realized And Unrealized Gainslosses TotalRealizedAndUnrealizedGainslosses	2303253	usd
CY2021Q4	pfx	Total Realized And Unrealized Gainslosses TotalRealizedAndUnrealizedGainslosses	4602899	usd
CY2022Q4	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	3951916	usd
CY2021Q4	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	4803010	usd
CY2022Q4	pfx	Earningsloss Per Share Of Common Stock Basic And Diluted EarningslossPerShareOfCommonStockBasicAndDiluted	1.88
CY2021Q4	pfx	Earningsloss Per Share Of Common Stock Basic And Diluted EarningslossPerShareOfCommonStockBasicAndDiluted	1.91
CY2022Q4	pfx	Income Loss From Continuing Operation Per Basic And Diluted Share IncomeLossFromContinuingOperationPerBasicAndDilutedShare	0.78
CY2021Q4	pfx	Income Loss From Continuing Operation Per Basic And Diluted Share IncomeLossFromContinuingOperationPerBasicAndDilutedShare	0.08
CY2022Q4	pfx	Weighted Average Shares Of Common Stock Outstanding Basic And Diluted WeightedAverageSharesOfCommonStockOutstandingBasicAndDiluted	2100876	shares
CY2021Q4	pfx	Weighted Average Shares Of Common Stock Outstanding Basic And Diluted WeightedAverageSharesOfCommonStockOutstandingBasicAndDiluted	2517221	shares
CY2022Q3	us-gaap	Assets Net AssetsNet	120845408	usd
CY2022Q4	us-gaap	Net Investment Income NetInvestmentIncome	1648663	usd
CY2022Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	13448	usd
CY2022Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2289805	usd
CY2022Q4	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	-104519	usd
CY2022Q4	pfx	Total Increase Decrease In Net Assets Value TotalIncreaseDecreaseInNetAssetsValue	3847397	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	124692805	usd
CY2021Q3	us-gaap	Assets Net AssetsNet	143693981	usd
CY2021Q4	us-gaap	Net Investment Income NetInvestmentIncome	200111	usd
CY2021Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	15223335	usd
CY2021Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-10324239	usd
CY2021Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-296197	usd
CY2021Q4	pfx	Total Increase Decrease In Net Assets Value TotalIncreaseDecreaseInNetAssetsValue	4803010	usd
CY2021Q4	us-gaap	Assets Net AssetsNet	148496991	usd
CY2022Q4	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	3951916	usd
CY2021Q4	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	4803010	usd
CY2022Q4	us-gaap-sup	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	195930	usd
CY2021Q4	us-gaap-sup	Interest And Dividend Income Operating Paid In Kind InterestAndDividendIncomeOperatingPaidInKind	235539	usd
CY2022Q4	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	72247	usd
CY2021Q4	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-2072	usd
CY2022Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	103192	usd
CY2021Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	41698	usd
CY2022Q4	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges	30431	usd
CY2022Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	13448	usd
CY2021Q4	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	15223335	usd
CY2022Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2289805	usd
CY2021Q4	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-10324239	usd
CY2022Q4	us-gaap-sup	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	19188416	usd
CY2021Q4	us-gaap-sup	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	77579123	usd
CY2022Q4	us-gaap-sup	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	6931516	usd
CY2021Q4	us-gaap-sup	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	96205833	usd
CY2021Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-296197	usd
CY2021Q4	pfx	Increase Decreasein Fees Recivable IncreaseDecreaseinFeesRecivable	-1872700	usd
CY2022Q4	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	985314	usd
CY2021Q4	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	161771	usd
CY2022Q4	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	29058	usd
CY2021Q4	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable	139248	usd
CY2022Q4	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable	287808	usd
CY2021Q4	pfx	Increase Decrease In Paydown Receivable IncreaseDecreaseInPaydownReceivable	3593630	usd
CY2022Q4	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-36992	usd
CY2021Q4	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1293	usd
CY2022Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-138264	usd
CY2021Q4	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-158901	usd
CY2022Q4	us-gaap	Increase Decrease In Payables To Broker Dealers IncreaseDecreaseInPayablesToBrokerDealers	-16550000	usd
CY2021Q4	us-gaap	Increase Decrease In Payables To Broker Dealers IncreaseDecreaseInPayablesToBrokerDealers	10503033	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-998141	usd
CY2021Q4	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-494108	usd
CY2021Q4	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates	-280460	usd
CY2022Q4	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	6644	usd
CY2021Q4	pfx	Increase Decreasein Administrator Expenses Payable IncreaseDecreaseinAdministratorExpensesPayable	-60045	usd
CY2021Q4	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	385729	usd
CY2022Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	146919	usd
CY2021Q4	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	386156	usd
CY2022Q4	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-37682	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4801463	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9922314	usd
CY2021Q4	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	57500000	usd
CY2021Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt	55325000	usd
CY2021Q4	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2305942	usd
CY2022Q4	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	312523	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-312523	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-130942	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5113986	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-10053256	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22768066	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69433256	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17654080	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59380000	usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet	1099553	usd
CY2021Q4	us-gaap	Interest Paid Net InterestPaidNet	1873404	usd
CY2022Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	104519	usd
CY2022Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.05	pure
CY2022Q4	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	17.92	shares
CY2022Q4	pfx	Commitment Fee Percentage On Undrawn Commitment CommitmentFeePercentageOnUndrawnCommitment	0.005	pure
CY2022Q3	us-gaap	Investment Owned Balance Shares InvestmentOwnedBalanceShares	1000	shares
CY2022Q3	pfx	Commitment Fee Percentage On Undrawn Commitment CommitmentFeePercentageOnUndrawnCommitment	0.005	pure
CY2022Q3	pfx	Nonaccrual Investments At Fair Value NonaccrualInvestmentsAtFairValue	5200000	usd
CY2022Q4	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Use of Estimates in the Preparation of Financial Statements</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p>
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	17700000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22800000	usd
CY2022Q4	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Indemnification</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In the normal course of business, the Company enters into contractual agreements that provide general indemnifications against losses, costs, claims and liabilities arising from the performance of individual obligations under such agreements. The Company has had no material claims or payments pursuant to such agreements. The Company’s individual maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Company that have not yet occurred. However, based on management’s experience, the Company expects the risk of loss to be remote.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p>
CY2022Q4	us-gaap	Revenue Recognition Interest RevenueRecognitionInterest	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><b>Revenue Recognition</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Interest income, adjusted for amortization of premiums and accretion of discounts, is recorded on an accrual basis. Dividend income, which represents dividends from equity investments and distributions from Taxable Subsidiaries, is recorded on the ex-dividend date and when the distribution is received, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company holds debt investments in its portfolio that contain a payment-in-kind (“PIK”) interest provision. PIK interest, which represents contractually deferred interest added to the investment balance that is generally due at maturity, is recorded on the accrual basis to the extent such amounts are expected to be collected. PIK interest is not accrued if the Company does not expect the issuer to be able to pay all principal and interest when due. For the three months ended December 31, 2022 and 2021, the Company earned approximately $0.2 million and $0.2 million in PIK interest, respectively.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Origination/closing, amendment and transaction break-up fees associated with investments in portfolio companies are recognized as income when we become entitled to such fees. Prepayment penalties received by the Company for debt instruments paid back to the Company prior to the maturity date are recorded as income upon repayment of debt. Administrative agent fees received by the Company are capitalized as deferred revenue and recorded as fee income when the services are rendered. For the three months ended December 31, 2022 and 2021, fee income was approximately $0.1 million, and $0.3 million, respectively (see Note 9).</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Investment transactions are accounted for on a trade date basis. Realized gains or losses on investments are measured by the difference between the net proceeds from the disposition and the amortized cost basis of investment, without regard to unrealized gains or losses previously recognized. During the three months ended December 31, 2022 and 2021, $0.0 million and $(19.6) million of the Company’s realized losses were related to certain non-cash restructuring transactions, which are recorded on the Consolidated Statements of Operations as a component of net realized gain/(loss) from investments. The Company reports changes in fair value of investments as a component of the net unrealized appreciation/(depreciation) on investments in the Consolidated Statements of Operations.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Management reviews all loans that become 90 days or more past due on principal or interest or when there is reasonable doubt that principal or interest will be collected for possible placement on management’s designation of non-accrual status. Interest receivable is analyzed regularly and may be reserved against when deemed not collectible. Interest payments received on non-accrual loans may be recognized as income or applied to principal depending upon management’s judgment regarding collectability. Non-accrual loans are restored to accrual status when past due principal and interest is paid and, in management’s judgment, are likely to remain current, although we may make exceptions to this general rule if the loan has sufficient collateral value and is in the process of collection. At December 31, 2022, certain investments in 5 portfolio companies held by the Company were on non-accrual status with a combined fair value of approximately $5.4 million, or 2.9% of the fair value of our portfolio. At September 30, 2022, certain investments in five portfolio companies held by the Company were on non-accrual status with a combined fair value of approximately $5.2 million, or 2.7% of the fair value of our portfolio.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p>
CY2022Q4	pfx	Payment In Kind Interest Income PaymentInKindInterestIncome	200000	usd
CY2021Q4	pfx	Payment In Kind Interest Income PaymentInKindInterestIncome	200000	usd
CY2022Q4	pfx	Fees Income FeesIncome	100000	usd
CY2021Q4	pfx	Fees Income FeesIncome	300000	usd
CY2022Q4	pfx	Nonaccrual Investments At Fair Value NonaccrualInvestmentsAtFairValue	5400000	usd
CY2022Q4	pfx	Portfolio Percentage At Fair Value PortfolioPercentageAtFairValue	0.029	pure
CY2022	pfx	Portfolio Percentage At Fair Value PortfolioPercentageAtFairValue	0.027	pure
CY2022Q4	pfx	Percentage Of Investment Company Taxable Income PercentageOfInvestmentCompanyTaxableIncome	0.90	pure
CY2022Q4	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.04	pure
CY2022Q4	pfx	Distributable Ordinary Income Percentage DistributableOrdinaryIncomePercentage	0.98	pure
CY2022Q4	pfx	Capital Gain Net Income Percentage CapitalGainNetIncomePercentage	0.982	pure
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	26300000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	26200000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	26300000	usd
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	26200000	usd
CY2022Q4	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b>Company Investment Risk, Concentration of Credit Risk, and Liquidity Risk</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company has broad discretion in making investments. Investments generally consist of debt instruments that may be affected by business, financial market or legal uncertainties. Prices of investments may be volatile, and a variety of factors that are inherently difficult to predict, such as domestic or international economic and political developments, may significantly affect the results of the Company’s activities and the value of its investments. In addition, the value of the Company’s portfolio may fluctuate as the general level of interest rates fluctuate.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The value of the Company’s investments in loans may be detrimentally affected to the extent, among other things, that a borrower defaults on its obligations, there is insufficient collateral and/or there are extensive legal and other costs incurred in collecting on a defaulted loan, observable secondary or primary market yields for similar instruments issued by comparable companies increase materially or risk premiums required in the market between smaller companies, such as our borrowers, and those for which market yields are observable increase materially.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The Company’s assets may, at any time, include securities and other financial instruments or obligations that are illiquid or thinly traded, making purchase or sale of such securities and financial instruments at desired prices or in desired quantities difficult. Furthermore, the sale of any such investments may be possible only at substantial discounts, and it may be extremely difficult to value any such investments accurately.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Company performance (including that of certain of its portfolio companies) has been and may continue to be negatively impacted by the COVID-19 pandemic’s effects. The COVID-19 pandemic has adversely impacted economies and capital markets around the world in ways that may continue and may change in unforeseen ways for an indeterminate period. The pandemic has also adversely affected various businesses, including some in which we are invested. The COVID-19 pandemic may exacerbate pre-existing business performance, political, social and economic risks affecting certain companies and countries generally. The impacts, as well as the uncertainty over impacts to come, of COVID-19 have adversely affected the performance of the Company (including certain portfolio companies) and may continue to do so in the future. Further, the potential exists for additional variants of COVID-19 to impede the global economic recovery and exacerbate geographic differences in the spread of, and response to, COVID-19.</span></p>
CY2022Q4	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	62600	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	183271000	usd
CY2022Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
CY2022Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	192957000	usd
CY2022Q3	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	183271000	usd
CY2022Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
CY2022Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	192957000	usd
CY2022Q3	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	1	pure
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	146675000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	7184000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-18297000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet	1659000	usd
CY2022Q4	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Realized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss	8000	usd
CY2022Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-1888000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	135341000	usd
CY2021Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	115813000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	65973000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySales	-73343000	usd
CY2021Q4	pfx	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Realized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInRealizedGainLoss	14295000	usd
CY2021Q4	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-14288000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	108450000	usd
CY2022Q4	pfx	Total Net Change In Unrealized Gainslosses TotalNetChangeInUnrealizedGainslosses	2300000	usd
CY2021Q4	pfx	Total Net Change In Unrealized Gainslosses TotalNetChangeInUnrealizedGainslosses	-10300000	usd
CY2022Q4	pfx	Investment Transferred Inout Description InvestmentTransferredInoutDescription	Reclassifications impacting Level 3 of the fair value hierarchy are reported as transfers in/out of the Level 3 category as of the beginning of the quarter in which the reclassifications occur. During the three months ended December 31, 2022, no investments were transferred out of Level 3 and one investment was transferred into Level 3. During the three months ended December 31, 2021, one of our investments transferred out of Level 3 and no investments transferred into Level 3.
CY2017Q3	pfx	Membership Interest Percentage MembershipInterestPercentage	0.05	pure
CY2017Q3	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	2400000	usd
CY2022Q4	pfx	Asset Coverage Percentage AssetCoveragePercentage	2	pure
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	80022000	usd
CY2022Q4	pfx	Debt Instrument Outstanding Amount DebtInstrumentOutstandingAmount	80022000	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	78066000	usd
CY2022Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	73033000	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	80022000	usd
CY2022Q3	pfx	Debt Instrument Outstanding Amount DebtInstrumentOutstandingAmount	80022000	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	77963000	usd
CY2022Q3	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	72633000	usd
CY2022Q4	us-gaap	Line Of Credit Assumed1 LineOfCreditAssumed1	50000000	usd
CY2022Q4	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.029	pure
CY2022Q4	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0025	pure
CY2022Q4	pfx	Aggregate Principal Amount AggregatePrincipalAmount	22521800	usd
CY2022Q4	pfx	Percentage Of Principal Amount PercentageOfPrincipalAmount	1	pure
CY2022Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	103000	usd
CY2021Q4	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	42000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	1203000	usd
CY2021Q4	us-gaap	Interest Expense InterestExpense	1488000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.061	pure
CY2021Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.075	pure
CY2022Q4	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	80022000	usd
CY2021Q4	pfx	Debt Instrument Weighted Average Outstanding Balance DebtInstrumentWeightedAverageOutstandingBalance	80022000	usd
CY2022Q4	us-gaap	Financing Interest Expense FinancingInterestExpense	30431	usd
CY2021Q4	us-gaap	Financing Interest Expense FinancingInterestExpense	0	usd
CY2022Q4	pfx	Administrative Services Expense AdministrativeServicesExpense	100000	usd
CY2021Q4	pfx	Administrative Services Expense AdministrativeServicesExpense	68866	usd
CY2022Q4	pfx	Investment Company Unfunded Commitments InvestmentCompanyUnfundedCommitments	2237000	usd
CY2022Q3	pfx	Investment Company Unfunded Commitments InvestmentCompanyUnfundedCommitments	6028000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The lease commenced September 1, 2021 and expires November 30, 2026.
CY2022Q3	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P4Y
CY2022Q4	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P4Y
CY2022Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0525	pure
CY2022Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0525	pure
CY2021Q4	pfx	Prepayment Fee Income PrepaymentFeeIncome	-209000	usd
CY2021Q4	pfx	Administrative Agent Fee Income AdministrativeAgentFeeIncome	-19000	usd
CY2021Q4	pfx	Amendment Fee Income AmendmentFeeIncome	4000	usd
CY2022Q4	pfx	Other Fees Income OtherFeesIncome	74000	usd
CY2021Q4	pfx	Other Fees Income OtherFeesIncome	38000	usd
CY2022Q4	pfx	Fees Income FeesIncome	74000	usd
CY2021Q4	pfx	Fees Income FeesIncome	270000	usd
CY2022Q4	pfx	Accrued Director Fees AccruedDirectorFees	200000	usd
CY2021Q4	pfx	Accrued Director Fees AccruedDirectorFees	0.0000002	usd
CY2022Q4	pfx	Average Debt Outstanding Per Common Sharein Shares AverageDebtOutstandingPerCommonShareinShares	38.09
CY2022Q4	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	3952000	usd
CY2021Q4	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	4803000	usd
CY2022Q4	pfx	Weighted Average Shares Of Common Stock Outstanding Basic And Diluted WeightedAverageSharesOfCommonStockOutstandingBasicAndDiluted	2100876	shares
CY2021Q4	pfx	Weighted Average Shares Of Common Stock Outstanding Basic And Diluted WeightedAverageSharesOfCommonStockOutstandingBasicAndDiluted	2517221	shares
CY2022Q4	pfx	Earningsloss Per Share Of Common Stock Basic And Diluted EarningslossPerShareOfCommonStockBasicAndDiluted	1.88
CY2021Q4	pfx	Earningsloss Per Share Of Common Stock Basic And Diluted EarningslossPerShareOfCommonStockBasicAndDiluted	1.91
CY2022Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	57.49
CY2021Q3	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	57.08
CY2022Q4	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.78
CY2021Q4	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.08
CY2022Q4	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	0.01
CY2021Q4	pfx	Realized Investment Gains Losses Per Share RealizedInvestmentGainsLossesPerShare	6.05
CY2022Q4	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	1.09
CY2021Q4	pfx	Unrealized Investment Gains Losses Per Share UnrealizedInvestmentGainsLossesPerShare	-4.1
CY2021Q4	us-gaap	Extinguishment Of Debt Gain Loss Per Share Net Of Tax ExtinguishmentOfDebtGainLossPerShareNetOfTax	-0.12
CY2022Q4	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	1.88
CY2021Q4	us-gaap	Investment Company Investment Income Loss From Operations Per Share InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare	1.91
CY2022Q4	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock	0.01
CY2022Q4	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.01
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	59.38
CY2021Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	58.99
CY2022Q4	us-gaap	Assets Net AssetsNet	124692805	usd
CY2021Q4	us-gaap	Assets Net AssetsNet	148496991	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2099824	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2517221	shares
CY2022Q4	us-gaap-sup	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	31.05
CY2021Q4	us-gaap-sup	Investment Company Market Value Per Share InvestmentCompanyMarketValuePerShare	41.83
CY2022Q4	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	-0.1098	pure
CY2021Q4	pfx	Investments Company Total Return Market Value InvestmentsCompanyTotalReturnMarketValue	1.346	pure
CY2022Q4	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0318	pure
CY2021Q4	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0141	pure
CY2022Q4	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	0.0375	pure
CY2021Q4	pfx	Portfolio Turnover Rate PortfolioTurnoverRate	1.8823	pure
CY2022Q4	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	0.0128	pure
CY2021Q4	us-gaap	Investment Company Investment Income Loss Ratio After Incentive Allocation InvestmentCompanyInvestmentIncomeLossRatioAfterIncentiveAllocation	-0.0008	pure
CY2022Q4	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0238	pure
CY2021Q4	us-gaap	Investment Company Expense Ratio After Incentive Allocation InvestmentCompanyExpenseRatioAfterIncentiveAllocation	0.0776	pure
CY2022Q4	pfx	Percentage Of Nonrecurring Fee Incomein Dollars PercentageOfNonrecurringFeeIncomeinDollars	0.0156	pure
CY2021Q4	pfx	Percentage Of Nonrecurring Fee Incomein Dollars PercentageOfNonrecurringFeeIncomeinDollars	0.0931	pure
CY2022Q4	us-gaap	Long Term Debt Average Amount Outstanding LongTermDebtAverageAmountOutstanding	80021800	usd
CY2021Q4	us-gaap	Long Term Debt Average Amount Outstanding LongTermDebtAverageAmountOutstanding	78934300	usd
CY2021Q4	pfx	Average Debt Outstanding Per Common Sharein Shares AverageDebtOutstandingPerCommonShareinShares	31.36
CY2022Q4	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2597	usd
CY2021Q4	pfx	Asset Coverage Ratio Per Unit AssetCoverageRatioPerUnit	2913	usd
CY2022Q4	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.78
CY2022Q4	pfx	Indebtedness Unit Amount IndebtednessUnitAmount	1000
CY2021Q4	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.08
CY2022Q4	pfx	Asset Coverage Description AssetCoverageDescription	the Company’s asset coverage was 259.7% after giving effect to leverage and therefore the Company’s asset coverage was above 200%, the minimum asset coverage requirement under the 1940 Act.
CY2022Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	624885	shares
CY2022Q4	pfx	Stock Repurchased And Retired During Period Values StockRepurchasedAndRetiredDuringPeriodValues	24783792	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2305	shares
CY2022	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	300	shares
CY2022Q4	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1000	shares
CY2022Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent		usd
CY2022Q4	us-gaap	Other Income OtherIncome		usd
CY2022Q4	pfx	Realized Gain Loss From Affiliate Investments RealizedGainLossFromAffiliateInvestments		usd
CY2022Q4	pfx	Realized Gain Loss From Control Investments RealizedGainLossFromControlInvestments		usd
CY2022Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q4	us-gaap	Amortization Of Deferred Charges AmortizationOfDeferredCharges		usd
CY2022Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q4	pfx	Increase Decreasein Fees Recivable IncreaseDecreaseinFeesRecivable		usd
CY2021Q4	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates		usd
CY2022Q4	us-gaap	Increase Decrease In Dividends Receivable IncreaseDecreaseInDividendsReceivable		usd
CY2022Q4	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		usd
CY2022Q4	us-gaap	Increase Decrease In Due To Affiliates IncreaseDecreaseInDueToAffiliates		usd
CY2021Q4	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities		usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
CY2022Q4	us-gaap	Repayments Of Debt RepaymentsOfDebt		usd
CY2022Q4	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2021Q4	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2021Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2022Q4	us-gaap	Debtor In Possession Financing Borrowings Outstanding DebtorInPossessionFinancingBorrowingsOutstanding		usd
CY2022Q4	us-gaap	Deferred Compensation Arrangement With Individual Cash Award Granted Amount DeferredCompensationArrangementWithIndividualCashAwardGrantedAmount		usd
CY2022Q4	pfx	Prepayment Fee Income PrepaymentFeeIncome		usd
CY2022Q4	pfx	Administrative Agent Fee Income AdministrativeAgentFeeIncome		usd
CY2022Q4	pfx	Amendment Fee Income AmendmentFeeIncome		usd
CY2021Q4	pfx	Investment Company Repurchases Of Commonstock InvestmentCompanyRepurchasesOfCommonstock
CY2021Q4	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
CY2022Q4	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001490349
CY2022Q3	us-gaap	Investment Interest Rate InvestmentInterestRate	0.013	pure

Files In Submission

Name	View Source	Status
0001213900-23-009500-index-headers.html	Edgar Link	pending
0001213900-23-009500-index.html	Edgar Link	pending
0001213900-23-009500.txt	Edgar Link	pending
0001213900-23-009500-xbrl.zip	Edgar Link	pending
f10q1222ex10-10_phenixfin.htm	Edgar Link	pending
f10q1222ex31-1_phenixfin.htm	Edgar Link	pending
f10q1222ex31-2_phenixfin.htm	Edgar Link	pending
f10q1222ex32-1_phenixfin.htm	Edgar Link	pending
f10q1222_phenixfincorp.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pfx-20221231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
pfx-20221231_cal.xml	Edgar Link	unprocessable
pfx-20221231_def.xml	Edgar Link	unprocessable
pfx-20221231_lab.xml	Edgar Link	unprocessable
pfx-20221231_pre.xml	Edgar Link	unprocessable
f10q1222_phenixfincorp_htm.xml	Edgar Link	completed
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PFX
PhenixFIN Corp Stock $pfx

2023 Q1 Form 10-Q Financial Statement

#000121390023009500 Filed on February 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PFX PhenixFIN Corp Stock $pfx

2023 Q1 Form 10-Q Financial Statement

#000121390023009500 Filed on February 09, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PFX
PhenixFIN Corp Stock $pfx